INPPL1 and cancer: SH2-containing inositol 5′-phosphatase 2 (SHIP2) belongs to the phosphoinositol phosphatases family which plays important role in modulating signaling pathways relevant to both diabetes and cancer and generally regulates insulin signaling, cytoskeleton remodeling, and receptor endocytosis [11–13].